191 related articles for article (PubMed ID: 35346312)
1. Molecular brain (micro report) oxytocin ameliorates impaired social behavior in a mouse model of 3q29 deletion syndrome.
Takemoto T; Baba M; Yokoyama K; Kitagawa K; Nagayasu K; Ago Y; Seiriki K; Hayata-Takano A; Kasai A; Mori D; Ozaki N; Takuma K; Hashimoto R; Hashimoto H; Nakazawa T
Mol Brain; 2022 Mar; 15(1):26. PubMed ID: 35346312
[TBL] [Abstract][Full Text] [Related]
2. Psychiatric-disorder-related behavioral phenotypes and cortical hyperactivity in a mouse model of 3q29 deletion syndrome.
Baba M; Yokoyama K; Seiriki K; Naka Y; Matsumura K; Kondo M; Yamamoto K; Hayashida M; Kasai A; Ago Y; Nagayasu K; Hayata-Takano A; Takahashi A; Yamaguchi S; Mori D; Ozaki N; Yamamoto T; Takuma K; Hashimoto R; Hashimoto H; Nakazawa T
Neuropsychopharmacology; 2019 Nov; 44(12):2125-2135. PubMed ID: 31216562
[TBL] [Abstract][Full Text] [Related]
3. Neuropsychiatric phenotypes and a distinct constellation of ASD features in 3q29 deletion syndrome: results from the 3q29 registry.
Pollak RM; Murphy MM; Epstein MP; Zwick ME; Klaiman C; Saulnier CA; ; Mulle JG
Mol Autism; 2019; 10():30. PubMed ID: 31346402
[TBL] [Abstract][Full Text] [Related]
4. Intranasal oxytocin administration ameliorates social behavioral deficits in a POGZ
Kitagawa K; Matsumura K; Baba M; Kondo M; Takemoto T; Nagayasu K; Ago Y; Seiriki K; Hayata-Takano A; Kasai A; Takuma K; Hashimoto R; Hashimoto H; Nakazawa T
Mol Brain; 2021 Mar; 14(1):56. PubMed ID: 33726803
[TBL] [Abstract][Full Text] [Related]
5. Mouse Model of Chromosome 15q13.3 Microdeletion Syndrome Demonstrates Features Related to Autism Spectrum Disorder.
Kogan JH; Gross AK; Featherstone RE; Shin R; Chen Q; Heusner CL; Adachi M; Lin A; Walton NM; Miyoshi S; Miyake S; Tajinda K; Ito H; Siegel SJ; Matsumoto M
J Neurosci; 2015 Dec; 35(49):16282-94. PubMed ID: 26658876
[TBL] [Abstract][Full Text] [Related]
6. Autism spectrum disorder symptom expression in individuals with 3q29 deletion syndrome.
Pollak RM; Pincus JE; Burrell TL; Cubells JF; Klaiman C; Murphy MM; Saulnier CA; Walker EF; White SP; Mulle JG
Mol Autism; 2022 Dec; 13(1):50. PubMed ID: 36566217
[TBL] [Abstract][Full Text] [Related]
7. Intranasal oxytocin in a genetic animal model of autism.
Szabó J; Mlynár M; Feješ A; Renczés E; Borbélyová V; Ostatníková D; Celec P
Mol Psychiatry; 2024 Feb; 29(2):342-347. PubMed ID: 38102481
[TBL] [Abstract][Full Text] [Related]
8. Targeting oxytocin receptor (Oxtr)-expressing neurons in the lateral septum to restore social novelty in autism spectrum disorder mouse models.
Horiai M; Otsuka A; Hidema S; Hiraoka Y; Hayashi R; Miyazaki S; Furuse T; Mizukami H; Teruyama R; Tamura M; Bito H; Maejima Y; Shimomura K; Nishimori K
Sci Rep; 2020 Dec; 10(1):22173. PubMed ID: 33335150
[TBL] [Abstract][Full Text] [Related]
9. Enhancing social behavior in an autism spectrum disorder mouse model: investigating the underlying mechanisms of
Chen CM; Wu CC; Kim Y; Hsu WY; Tsai YC; Chiu SL
Gut Microbes; 2024; 16(1):2359501. PubMed ID: 38841895
[TBL] [Abstract][Full Text] [Related]
10. Study protocol for The Emory 3q29 Project: evaluation of neurodevelopmental, psychiatric, and medical symptoms in 3q29 deletion syndrome.
Murphy MM; Lindsey Burrell T; Cubells JF; España RA; Gambello MJ; Goines KCB; Klaiman C; Li L; Novacek DM; Papetti A; Sanchez Russo RL; Saulnier CA; Shultz S; Walker E; Mulle JG
BMC Psychiatry; 2018 Jun; 18(1):183. PubMed ID: 29884173
[TBL] [Abstract][Full Text] [Related]
11. Behavioral changes and growth deficits in a CRISPR engineered mouse model of the schizophrenia-associated 3q29 deletion.
Rutkowski TP; Purcell RH; Pollak RM; Grewenow SM; Gafford GM; Malone T; Khan UA; Schroeder JP; Epstein MP; Bassell GJ; Warren ST; Weinshenker D; Caspary T; Mulle JG
Mol Psychiatry; 2021 Mar; 26(3):772-783. PubMed ID: 30976085
[TBL] [Abstract][Full Text] [Related]
12. Oxytocin levels and sex differences in autism spectrum disorder with severe intellectual disabilities.
Aita C; Mizoguchi Y; Yamamoto M; SeguchI Y; Yatsuga C; Nishimura T; Sugimoto Y; Takahashi D; Nishihara R; Ueno T; Nakayama M; Kuroki T; Nabeta H; Imamura Y; Monji A
Psychiatry Res; 2019 Mar; 273():67-74. PubMed ID: 30640053
[TBL] [Abstract][Full Text] [Related]
13. OTUD7A Regulates Neurodevelopmental Phenotypes in the 15q13.3 Microdeletion Syndrome.
Uddin M; Unda BK; Kwan V; Holzapfel NT; White SH; Chalil L; Woodbury-Smith M; Ho KS; Harward E; Murtaza N; Dave B; Pellecchia G; D'Abate L; Nalpathamkalam T; Lamoureux S; Wei J; Speevak M; Stavropoulos J; Hope KJ; Doble BW; Nielsen J; Wassman ER; Scherer SW; Singh KK
Am J Hum Genet; 2018 Feb; 102(2):278-295. PubMed ID: 29395074
[TBL] [Abstract][Full Text] [Related]
14. Neonatal Oxytocin Treatment Ameliorates Autistic-Like Behaviors and Oxytocin Deficiency in Valproic Acid-Induced Rat Model of Autism.
Dai YC; Zhang HF; Schön M; Böckers TM; Han SP; Han JS; Zhang R
Front Cell Neurosci; 2018; 12():355. PubMed ID: 30356897
[TBL] [Abstract][Full Text] [Related]
15. Familial inheritance of the 3q29 microdeletion syndrome: case report and review.
Khan WA; Cohen N; Scott SA; Pereira EM
BMC Med Genomics; 2019 Mar; 12(1):51. PubMed ID: 30885185
[TBL] [Abstract][Full Text] [Related]
16. Oxytocin in the regulation of social behaviours in medial amygdala-lesioned mice via the inhibition of the extracellular signal-regulated kinase signalling pathway.
Wang Y; Zhao S; Wu Z; Feng Y; Zhao C; Zhang C
Clin Exp Pharmacol Physiol; 2015 May; 42(5):465-74. PubMed ID: 25707920
[TBL] [Abstract][Full Text] [Related]
17. Autism-relevant behaviors are minimally impacted by conditional deletion of Pten in oxytocinergic neurons.
Clipperton-Allen AE; Chen Y; Page DT
Autism Res; 2016 Dec; 9(12):1248-1262. PubMed ID: 27220363
[TBL] [Abstract][Full Text] [Related]
18. The effects of oxytocin administration on individuals with ASD: Neuroimaging and behavioral evidence.
Baker E; Stavropoulos KKM
Prog Mol Biol Transl Sci; 2020; 173():209-238. PubMed ID: 32711811
[TBL] [Abstract][Full Text] [Related]
19. The oxytocin receptor gene polymorphism rs2268491 and serum oxytocin alterations are indicative of autism spectrum disorder: A case-control paediatric study in Iraq with personalized medicine implications.
Al-Ali Z; Yasseen AA; Al-Dujailli A; Al-Karaqully AJ; McAllister KA; Jumaah AS
PLoS One; 2022; 17(3):e0265217. PubMed ID: 35316293
[TBL] [Abstract][Full Text] [Related]
20. NCBP2 modulates neurodevelopmental defects of the 3q29 deletion in Drosophila and Xenopus laevis models.
Singh MD; Jensen M; Lasser M; Huber E; Yusuff T; Pizzo L; Lifschutz B; Desai I; Kubina A; Yennawar S; Kim S; Iyer J; Rincon-Limas DE; Lowery LA; Girirajan S
PLoS Genet; 2020 Feb; 16(2):e1008590. PubMed ID: 32053595
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
